CRSP Today - Jul 17: Six-Day Slide Continues

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

CRSP Today - Jul 17: Six-Day Slide Continues

無料で聴く

ポッドキャストの詳細を見る

Hey there! I’m Joey, your friendly neighborhood investor, here to break down what went down with CRISPR Therapeutics today. So, CRSP had a bit of a rough ride, closing down about half a percent. Yeah, it’s been a tough week.

Now, here’s the scoop. CRISPR has been sliding for six straight days. That’s right, six! People are starting to wonder if it’s finally hit a cheap price, but honestly, it still feels like a slow bleed. Volume was way below average today, which means not a lot of folks were trading it. It’s like everyone’s holding their breath, waiting to see what happens next.

So, why the drop? Well, a couple of articles pointed to some serious market pressure. It seems like investors are getting a little jittery about the biotech sector overall. Plus, some chatter around Intellia Therapeutics is stealing the spotlight. They’ve got some exciting stuff cooking in their pipeline, and it’s leaving CRISPR looking a bit overshadowed. Nobody really knows if this slide is just a temporary dip or something more serious.

And speaking of the future, CRISPR’s got about $2.4 billion in cash on hand. So, they’re not exactly in a tight spot. That’s definitely something to keep in mind.

To wrap it up, CRISPR’s been on a rough patch lately, and while some folks are wondering if it’s a good time to jump in, it’s still a wait-and-see game. Just remember, this is all for info and fun, not financial advice. Catch you later!

まだレビューはありません